Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (391-400 of 447) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
BMC Genomics|April 29, 2006
The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Cheng Fan, Daniel S Oh, et al.
Nature Communications|March 1, 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancerAleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, et al.
Breast Cancer Research : BCR|February 8, 2018
Frequency of breast cancer subtypes among African American women in the AMBER consortiumEmma H Allott, Joseph Geradts, Stephanie M Cohen, et al.
JAMA Oncology|April 27, 2023
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without PertuzumabCoralia Bueno-Muiño, Isabel Echavarría, Sara López-Tarruella, et al.
Cancer Research|June 6, 2013
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft modelsXiaomei Zhang, Sofie Claerhout, Aleix Prat, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Quantitative proteomic mass spectrometry of protein kinases to determine dynamic heterogeneity of the human kinomeMichael P East, Robert W Sprung, Denis O Okumu, et al.
Cell|April 17, 2012
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancerJames S Duncan, Martin C Whittle, Kazuhiro Nakamura, et al.
BMC Medical Genomics|October 6, 2012
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markersRoy R L Bastien, Álvaro Rodríguez-Lescure, Mark T W Ebbert, et al.
Pageof 45

Showing results (391-400 of 447) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
BMC Genomics|April 29, 2006
The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Cheng Fan, Daniel S Oh, et al.
Nature Communications|March 1, 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancerAleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, et al.
Breast Cancer Research : BCR|February 8, 2018
Frequency of breast cancer subtypes among African American women in the AMBER consortiumEmma H Allott, Joseph Geradts, Stephanie M Cohen, et al.
JAMA Oncology|April 27, 2023
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without PertuzumabCoralia Bueno-Muiño, Isabel Echavarría, Sara López-Tarruella, et al.
Cancer Research|June 6, 2013
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft modelsXiaomei Zhang, Sofie Claerhout, Aleix Prat, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Quantitative proteomic mass spectrometry of protein kinases to determine dynamic heterogeneity of the human kinomeMichael P East, Robert W Sprung, Denis O Okumu, et al.
Cell|April 17, 2012
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancerJames S Duncan, Martin C Whittle, Kazuhiro Nakamura, et al.
BMC Medical Genomics|October 6, 2012
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markersRoy R L Bastien, Álvaro Rodríguez-Lescure, Mark T W Ebbert, et al.
Pageof 45